Burrows Francis
- SEC CIK
- 0002051119
In the past year, 3 open-market sale filings worth $467.6K and no purchases.
Current role at each company
- KURA Kura Oncology, Inc.Chief Scientific Officeras of Sep 25, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $467.6K
- 3 filings
- Net
- −$467.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Burrows Francis as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 28, 2025 (view filing) | Jan 28 | Same day | Burrows FrancisChief Scientific Officer | SSale | −2.17K | $7.87 | −$17.0K | −9.5%20.7K after | 2 lots |
| Dec 19, 2025 (view filing) | Dec 18 | 1 day | Burrows FrancisChief Scientific Officer | SSale | −23.7K | $9.78 | −$232.0K | −41.3%33.7K after | |
| Jan 27, 2026 (view filing) | Jan 27 | Same day | Burrows FrancisChief Scientific Officer | SSale | −1.31K | $8.46 | −$11.1K | −3.9%32.4K after | |
| Sep 25, 2026 (view filing)4:05 PM ET | Sep 24 | 1 day | Burrows FrancisChief Scientific Officer | SSale | −20.7K | $10.83 | −$224.5K | −32.9%42.3K after |